Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BW.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FB.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CJ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.65NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DT.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DS.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBKNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.14.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DF.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.1.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.33.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used